Magnetic Resonance and Artificial Intelligence:

Genus Focus’s in-ovo sexing.

 

 

In poultry farming, the ability to determine the gender of a chick before its birth represents a transformation in terms of efficiency and animal welfare. Genus Focus emerges as a revolutionary solution in this area, using cutting-edge technology for non-invasive in-ovo sexing.

How does Genus Focus work?

Using magnetic resonance technology combined with artificial intelligence, Genus Focus scans poultry eggs up to day 12 of embryonic development. It then classifies them into categories: females, males, unfertilized eggs, and early death eggs. Its versatility is such that it can operate regardless of egg color or chicken breed, and it ensures that the process does not affect the egg’s hatchability. With a capacity of 3,000 eggs per hour per module, and expandability up to 8 modules, it achieves an impressive throughput of 24,000 eggs per hour.

Safety and animal welfare.

What sets Genus Focus apart is not just its efficiency but also its respect for animal welfare. Unlike X-ray or CT scan techniques, it does not emit ionizing radiation, thus protecting embryonic development. Moreover, it is a completely non-invasive process. These advances align with a recent study from the German Federal Ministry of Food and Agriculture (BMEL), which states that neural activity in chick embryos does not begin before day 13, meaning they cannot feel pain before this day.

The importance of data.

Modern poultry farming relies on accurate data to improve the efficiency and welfare of birds. While information on daily production, climatic conditions, and resource consumption is essential, embryodiagnosis and constant monitoring offer a more detailed view of bird health and performance. Vencomatic Group, understanding the importance of this data, strives to provide relevant information to support informed decisions in poultry farms.

Expert testimony.

Dr. Maria Laparidou, from Orbem, strongly endorses Genus Focus technology. According to her, recent findings on pain perception in embryos reinforce that this non-invasive technology is the right direction for animal welfare.

Collaboration and future.

The collaboration between Orbem and Vencomatic Group has been crucial for the development of Genus Focus. Combining Orbem’s technological approach with Vencomatic’s Prinzen automated egg handling system, both companies anticipate prompt implementation in Germany, especially with upcoming regulations allowing in-ovo sexing up to day 12 after January 1, 2024.

About Orbem.

Based in Munich, Orbem conducts advanced research in artificial intelligence, imaging technology, and bird embryonic development. Their vision is clear: to develop solutions for a healthy and sustainable future in poultry farming and beyond.

The introduction of Genus Focus in the poultry market marks a turning point. Its adoption is expected to bring significant advancements in both productive efficiency and animal welfare.